Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132440) titled 'Study on the mechanism of metformin regulating macrophage death to improve pre-eclampsia through TLR4/NF-KB/NLRP3 axis' on Sept. 14.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Zhejiang Xiaoshan Hospital
Condition:
Pre-eclampsia,PE
Intervention:
Normal pregnant group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Normal pregnant group:15;Preeclampsia pregnant group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=326676
Published by HT Digital Co...